Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer

Gynecologic Oncology

Volumn 120, Issue 2, 2011, Pages 270-274

  Chung, Hyun Hoon ^a   Kim, Jae Weon ^a   Han, Kyung Hee ^a   Eo, Jae Seon ^a   Kang, Keon Wook ^a   Park, Noh Hyun ^a   Song, Yong Sang ^a   Chung, June Key ^a   Kang, Soon Beom ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Cervical cancer; Metabolic tumor volume; PET CT; Recurrence; Surgery

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CANCER INVASION; CANCER RECURRENCE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; METABOLIC TUMOR VOLUME; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; RECEIVER OPERATING CHARACTERISTIC; RECURRENT DISEASE; TUMOR VOLUME; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 79251601258     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.11.002     Document Type: Article

References (31)

1. L.H. Ellenson, and T.C. Wu Focus on endometrial and cervical cancer Cancer Cell 5 2004 533 538
2. Y.T. Kim Current status of cervical cancer and HPV infection in Korea J Gynecol Oncol 20 2009 1 7
3. C.H. Han, H.J. Cho, S.J. Lee, J.H. Bae, S.N. Bae, and S.E. Namkoong The increasing frequency of cervical cancer in Korean women under 35 Cancer Res Treat 40 2008 1 5
4. J.L. Benedet, F. Odicino, P. Maisonneuve, U. Beller, W.T. Creasman, and A.P. Heintz Carcinoma of the cervix uteri J Epidemiol Biostat 6 2001 7 43
5. F. Landoni, A. Maneo, A. Colombo, F. Placa, R. Milani, and P. Perego Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer Lancet 350 1997 535 540
6. C.K. Chung, W.A. Nahhas, J.A. Stryker, S.L. Curry, A.B. Abt, and R. Mortel Analysis of factors contributing to treatment failures in stages IB and IIA carcinoma of the cervix Am J Obstet Gynecol 138 1980 550 556
7. van Nagell J.R. Jr., Donaldson E.S., Wood E.G., and Parker J.C. Jr. The significance of vascular invasion and lymphocytic infiltration in invasive cervical cancer Cancer 41 1978 228 234
8. G. Delgado, B. Bundy, R. Zaino, B.U. Sevin, W.T. Creasman, and F. Major Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study Gynecol Oncol 38 1990 352 357
9. J. Boyce, R.G. Fruchter, A.D. Nicastri, P.C. Ambiavagar, M.S. Reinis, and J.H. Nelson Jr. Prognostic factors in stage I carcinoma of the cervix Gynecol Oncol 12 1981 154 165
10. S.E. Waggoner Cervical cancer Lancet 361 2003 2217 2225
11. M. Werner-Wasik, C.H. Schmid, L. Bornstein, H.G. Ball, D.M. Smith, and H. Madoc-Jones Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma Int J Radiat Oncol Biol Phys 32 1995 1309 1317
12. L.C. Horn, U. Fischer, G. Raptis, K. Bilek, and B. Hentschel Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer Gynecol Oncol 107 2007 310 315
13. A.S. Allal, P. Dulguerov, M. Allaoua, C.A. Haenggeli, A. El-Ghazi el, and W. Lehmann Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy J Clin Oncol 20 2002 1398 1404
14. R. Sasaki, R. Komaki, H. Macapinlac, J. Erasmus, P. Allen, and K. Forster [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer J Clin Oncol 23 2005 1136 1143
15. A. Davies, C. Tan, C. Paschalides, S.F. Barrington, M. O'Doherty, and M. Utley FDG-PET maximum standardised uptake value is associated with variation in survival: analysis of 498 lung cancer patients Lung Cancer 55 2007 75 78
16. H. Minn, M. Lapela, P.J. Klemi, R. Grenman, S. Leskinen, and P. Lindholm Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer J Nucl Med 38 1997 1907 1911
17. P. Lee, D.K. Weerasuriya, P.W. Lavori, A. Quon, W. Hara, and P.G. Maxim Metabolic tumor burden predicts for disease progression and death in lung cancer Int J Radiat Oncol Biol Phys 69 2007 328 333
18. M.K. Chung, H.S. Jeong, S.G. Park, J.Y. Jang, Y.I. Son, and J.Y. Choi Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer Clin Cancer Res 15 2009 5861 5868
19. M.K. Chung, H.S. Jeong, Y.I. Son, Y.K. So, G.Y. Park, and J.Y. Choi Metabolic tumor volumes by [18F]-fluorodeoxyglucose PET/CT correlate with occult metastasis in oral squamous cell carcinoma of the tongue Ann Surg Oncol 16 2009 3111 3117
20. T.H. La, E.J. Filion, B.B. Turnbull, J.N. Chu, P. Lee, and K. Nguyen Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer Int J Radiat Oncol Biol Phys 74 2009 1335 1341
21. T.R. Miller, and P.W. Grigsby Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy Int J Radiat Oncol Biol Phys 53 2002 353 359
22. C. Greco, K. Rosenzweig, G.L. Cascini, and O. Tamburrini Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC) Lung Cancer 57 2007 125 134
23. C. Scarfone, W.C. Lavely, A.J. Cmelak, D. Delbeke, W.H. Martin, and D. Billheimer Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging J Nucl Med 45 2004 543 552
24. K.J. Biehl, F.M. Kong, F. Dehdashti, J.Y. Jin, S. Mutic, and I. El Naqa 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate? J Nucl Med 47 2006 1808 1812
25. J.D. Bradley, N. Ieumwananonthachai, J.A. Purdy, T.H. Wasserman, M.A. Lockett, and M.V. Graham Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma Int J Radiat Oncol Biol Phys 52 2002 49 57
26. U. Nestle, S. Kremp, A. Schaefer-Schuler, C. Sebastian-Welsch, D. Hellwig, and C. Rube Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer J Nucl Med 46 2005 1342 1348
27. S.W. Lee, S.Y. Nam, K.C. Im, J.S. Kim, E.K. Choi, and S.D. Ahn Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d- glucose positron emission tomography for nasopharyngeal carcinomas Radiother Oncol 87 2008 211 216
28. I.F. Ciernik, E. Dizendorf, B.G. Baumert, B. Reiner, C. Burger, and J.B. Davis Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study Int J Radiat Oncol Biol Phys 57 2003 853 863
29. H. Ashamalla, S. Rafla, K. Parikh, B. Mokhtar, G. Goswami, and S. Kambam The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer Int J Radiat Oncol Biol Phys 63 2005 1016 1023
30. H.H. Chung, B.H. Nam, J.W. Kim, K.W. Kang, N.H. Park, and Y.S. Song Preoperative [18F]FDG PET/CT maximum standardized uptake value predicts recurrence of uterine cervical cancer Eur J Nucl Med Mol Imaging 37 2010 1467 1473
31. S.H. Hyun, J.Y. Choi, Y.M. Shim, K. Kim, S.J. Lee, and Y.S. Cho Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma Ann Surg Oncol 17 2010 115 122